Chief executive
Christopher Boerner
Chief Executive Officer · Bristol Myers Squibb Co
1 disclosed trade · 20 Feb 2025 to 20 Feb 2025 · latest filed 21 Feb 2025
Chief executive of Bristol Myers Squibb Co (BMY), tracked from the executive's own SEC Form 4 disclosures.
Net buying by company
| Company | Share of net buying | Est. net |
|---|---|---|
| Common Stock, $0.10 par value (BMY) | 100.0% | $110K |
Recent disclosed trades
| Company | Trade date | Action | Amount |
|---|---|---|---|
| Common Stock, $0.10 par value (BMY) | 2025-02-20 | Buy | $110,096 |
Source: SEC Form 4 filings, trades from 20 Feb 2025 to 20 Feb 2025, latest filed 21 Feb 2025. Executives report their own trades on Form 4 within two business days.
Open the interactive profile: all trades, compare with others